Back

Early initiation of disease-modifying therapy in patients with suspected heart failure

29 August 2025 (17:00 - 17:15)
Organised by: Logo
Congress Presentation Part of: Late Breaking Clinical Science: global insights and outcomes in heart failure Treatment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Kieran Docherty

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
ESC HF III Registry - primary analysis: outcomes
Professor L. Lund (Stockholm, SE)
Slides Video
Presentation thumbnail
Temporal Trends in HF Outcomes
Professor J. Youn (Seoul, KR)
Slides Video
Presentation thumbnail
THESUS HF II Acute Heart Failure in Africa
Professor K. Sliwa (Cape Town, ZA)
Slides Video

Access the full session

Session thumbnail
Late Breaking Clinical Science: global insights and outcomes in heart failure
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 17:00 CET
You may be interested in
thumbnail
Congress Session
Advances in heart failure detection and therapy
10 May 2026
thumbnail
Congress Presentation
To describe the prevalence of elevated natriuretic peptide and its trend over time, in a high risk diabetic population - a retrospective study
18 May 2025
thumbnail
Congress Presentation
Sodium-glucose co-transporter-2 inhibitors: prognostic benefit in real-world, elderly, comorbid HFmrEF and HFpEF patients
19 May 2025
thumbnail
Congress Presentation
Real-world monocentric experience of early impact of SGLT2 inhibitors on NT-proBNP levels in heart failure
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources